An interventional study of Bilateral mastectomy and Biopsy in Female Breast Cancer and Male Breast Cancer, sponsored by Centro Hospitalar Lisboa Ocidental. Status unknown. Open to participants aged 40 Years and older. Per ClinicalTrials.gov, last updated 2017-11-28.
Sponsored by Centro Hospitalar Lisboa Ocidental · Not applicable, Interventional, and Diagnostic
The aim of this study is to define silent breast cancer prevalence in both sexes and will be held by biopsies performed in imaging suspicious areas of the breast (ecography and mammography) in cadavers without known breast cancer.
Cadavers of both sexes are going to be submitted to bilateral mastectomy. The specimens are going to be examined by palpation, ecography and mammography and all areas with (Breast Imaging Reporting and Data System) BI-RADS classification >= 3 are going to be biopsied.
Biopsy specimens are going to be processed by the pathology department and cancers are going to be identified and classified by their molecular type.
The investigators intend to know which is the disease reservoir in various ages.
286 studies on the registry are indexed under Breast Neoplasms, Male; 5 are open to participants now.
This study's planned enrollment of 768 is above the median of 37 across 230 interventional studies indexed under Breast Neoplasms, Male.
Browse Breast Neoplasms, Male studies →Centro Hospitalar Lisboa Ocidental is the lead sponsor of 9 studies on the registry; none are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
female cadavers above 40 years without known breast cancer Bilateral mastectomy Biopsy
Procedure: Bilateral mastectomy · Other: Biopsy
male cadavers above 40 years without known breast cancer Bilateral mastectomy Biopsy
Procedure: Bilateral mastectomy · Other: Biopsy
Bilateral mastectomy and imaging study of cadaveric breasts
Biopsy of BI-RADS 3 and superior lesions
Silent breast cancer prevalence
To define the existing disease that did not caused death in both sexes
Time frame: 2 years
Silent breast cancer prevalent molecular profile
To identify those molecular subgroups of the disease that remain silent
Time frame: 2 years
No study locations are listed for this record.
Plan to share: No
No publications or documents are linked to this record.
This study is status unknown, as verified in Nov 2017. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Centro Hospitalar Lisboa Ocidental